WuXi virology platforms: Immunology, Anti viral, Viral Vector, Oligo-nucleotide, Clinical and Immunology in vitro screening and profiling in vivo efficacy clinical virology Liver-specific viruses | Respiratory viruses | Herpes viruses | Other viruses

Comprehensive in vitro off-target screening services WuXi Biology provides in vitro safety pharmacology services to identify potential off-target liabilities. Three choices can be selected: • WuXi AppTec Mini Safety 44 Panel (Mini Safety 44 Panel) A primary safety panel, which is designed to identify compounds with the highest risk because it contains targets associated with …Read More >

Identify Potential Liability Issues in the Early Stages of Drug Discovery In response to the growing need for early-stage in vitro toxicity testing, WuXi Biology provides a suite of toxicity assays at the cellular level. Using advanced technologies like automated patch-clamp and high content screening (HCS), these assays can be applied to your lead ID …Read More >

A Platform Supporting HBV Drug Discovery A broad assay platform for the discovery of agents for the treatment of chronic HBV infection. Services for assay establishment and validation, compound screening and profiling, and support of preclinical studies and clinical trials. Drug screening using HBV producing cell lines HBV infectious assays Reporter assays Core protein expression …Read More >

Clinical Virology and Advanced Therapy Platforms Research Services: CAP Accredited Molecular Testing Laboratory Genetics and Biomarker Platform HBV Genotyping Assays HBV Serology Assays HBV Phenotyping Assays Immunological Assays Other Assays:  Oncolytic |  CAR-T/TCR-T Particular Solutions Clinical virology: Viral load, sequencing, genotyping, TCID50, phenotyping, virus isolation and characterization, serology Vaccines: Advanced therapies (Viral vector and cell therapies): …Read More >